In a separate statement, Sanghvi said that although the formal shareholder agreement has been cancelled, he and his affiliated firms will remain investors in Suzlon Energy.
The summit 'Advantage Assam', being organised on February 3-4 at a total expenditure of Rs 32 crore, will also witness participation of business leaders and ministers from as many as 20 countries such as the ASEAN nations, the US, Czech Republic, Germany, Japan, UAE and Israel.
The bipartisan support for India from Democratic and Republican Senators was fantastic, said Pepsico-India Holdings Chairman and CEO D Shivakumar, adding, America's innovativeness, start-up and R&D combined with India's entrepreneurship on both product and services has a huge potential for both the countries.
Dilip Shanghvi has agreed to buy a 23 percent stake in Indian wind turbine maker Suzlon Energy for about USD 290 million.
Yesterday Natco Pharma has raised Rs 67.5 crore via QIP. They issued 3 million shares at Rs 225 per share, reports CNBC-TV18.
Sun Pharma is all set to enter the lucrative oral contraceptive market in the US, but the going won’t be easy with the entrenched players like Teva and Watson dominating the market. CNBC-TV18’s Archana Shukla reports Sun will even have to take on its Indian peers like Glenmark and Lupin, who have an early mover advantage.